Correlia Biosystems Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $1.25M

  • Investors
  • 21

Correlia Biosystems General Information

Description

Developer of a streamlined microscale assay platform designed to reduce the time and cost of quantifying proteins for proteomics and pharmaceutical applications. The company's platform provides multiplexing capabilities for large protein panels including cytokines and post-translational modifications with unparalleled speed and automation, enabling researchers to obtain large panel protein studies and reducing the cost and time to market for candidate drug compounds.

Contact Information

Website
correliabio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 626 Bancroft Way
  • Suite A
  • Berkeley, CA 94710
  • United States
+1 (510)
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 626 Bancroft Way
  • Suite A
  • Berkeley, CA 94710
  • United States
+1 (510)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Correlia Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC (Series A1) 09-May-2023 $1.25M Completed Generating Revenue
13. Later Stage VC (Series A) 01-Oct-2020 Completed Generating Revenue
12. Accelerator/Incubator Completed Generating Revenue
11. Grant 31-Jan-2020 Completed Generating Revenue
10. Accelerator/Incubator Completed Generating Revenue
9. Accelerator/Incubator 19-Mar-2018 Completed Generating Revenue
8. Grant 01-Sep-2016 Completed Generating Revenue
7. Accelerator/Incubator 01-Nov-2014 Completed Generating Revenue
6. Accelerator/Incubator 01-Aug-2014 $5K Completed Generating Revenue
5. Grant 01-Jul-2014 $450K $5K Completed Generating Revenue
To view Correlia Biosystems’s complete valuation and funding history, request access »

Correlia Biosystems Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-1
Series A-3
Series A-2 1,091,449 $0.000100 6% $0.44 $0.44 1x $0.44 2.74%
To view Correlia Biosystems’s complete cap table history, request access »

Correlia Biosystems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a streamlined microscale assay platform designed to reduce the time and cost of quantifying proteins for pr
Discovery Tools (Healthcare)
Berkeley, CA
15 As of 2024

Munich, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Correlia Biosystems Competitors (1)

One of Correlia Biosystems’s competitors is PreOmics, a Venture Capital-Backed company based in Munich, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PreOmics Venture Capital-Backed Munich, Germany
You’re viewing 1 of 1 competitors. Get the full list »

Correlia Biosystems Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Correlia Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230139925-A1 Automated analyte measurement systems and kits for use therewith Pending 24-Jan-2020

Correlia Biosystems Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Correlia Biosystems Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds
Freerun Ventures Secondary Buyer Minority
Baidu Ventures Corporate Venture Capital Minority
Beresford Ventures Venture Capital Minority
Blue Bear Ventures Venture Capital Minority
Cota Capital Venture Capital Minority
You’re viewing 5 of 21 investors. Get the full list »

Ready to get started?

Request a free trial

Correlia Biosystems FAQs

  • When was Correlia Biosystems founded?

    Correlia Biosystems was founded in 2013.

  • Where is Correlia Biosystems headquartered?

    Correlia Biosystems is headquartered in Berkeley, CA.

  • What is the size of Correlia Biosystems?

    Correlia Biosystems has 15 total employees.

  • What industry is Correlia Biosystems in?

    Correlia Biosystems’s primary industry is Discovery Tools (Healthcare).

  • Is Correlia Biosystems a private or public company?

    Correlia Biosystems is a Private company.

  • What is the current valuation of Correlia Biosystems?

    The current valuation of Correlia Biosystems is .

  • What is Correlia Biosystems’s current revenue?

    The current revenue for Correlia Biosystems is .

  • How much funding has Correlia Biosystems raised over time?

    Correlia Biosystems has raised $11M.

  • Who are Correlia Biosystems’s investors?

    Freerun Ventures, Baidu Ventures, Beresford Ventures, Blue Bear Ventures, and Cota Capital are 5 of 21 investors who have invested in Correlia Biosystems.

  • Who are Correlia Biosystems’s competitors?

    PreOmics is a competitor of Correlia Biosystems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »